111 related articles for article (PubMed ID: 27122187)
1. PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance in B-lymphoproliferative disorders.
Wang D; Chen J; Li R; Wu G; Sun Z; Wang Z; Zhai Z; Fang F; Guo Y; Zhong Y; Jiang M; Xu H; Chen M; Shen G; Sun J; Yan B; Yu C; Tian Z; Xiao W
J Cell Sci; 2016 Jun; 129(11):2261-72. PubMed ID: 27122187
[TBL] [Abstract][Full Text] [Related]
2. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner.
Cai X; Du J; Liu Y; Xia W; Liu J; Zou M; Wang Y; Wang M; Su H; Xu D
Gene; 2013 Apr; 517(2):205-11. PubMed ID: 23333941
[TBL] [Abstract][Full Text] [Related]
4. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2.
Maharana J; Dehury B; Sahoo JR; Jena I; Bej A; Panda D; Sahoo BR; Patra MC; Pradhan SK
Mol Biosyst; 2015 Aug; 11(8):2324-36. PubMed ID: 26079944
[TBL] [Abstract][Full Text] [Related]
6. RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells.
Jaafar R; Mnich K; Dolan S; Hillis J; Almanza A; Logue SE; Samali A; Gorman AM
Biochem Biophys Res Commun; 2018 Feb; 497(1):115-121. PubMed ID: 29421659
[TBL] [Abstract][Full Text] [Related]
7. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
[TBL] [Abstract][Full Text] [Related]
8. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
[TBL] [Abstract][Full Text] [Related]
9. RIP2-beta: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2.
Krieg A; Le Negrate G; Reed JC
Mol Immunol; 2009 Mar; 46(6):1163-70. PubMed ID: 19121870
[TBL] [Abstract][Full Text] [Related]
10. Engagement of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) by receptor-interacting protein 2 (RIP2) is insufficient for signal transduction.
Mayle S; Boyle JP; Sekine E; Zurek B; Kufer TA; Monie TP
J Biol Chem; 2014 Aug; 289(33):22900-22914. PubMed ID: 24958724
[TBL] [Abstract][Full Text] [Related]
11. Prokaryotic expression, purification and functional characterization of recombinant human RIP2.
Cai X; Wang M; Kong H; Liu J; Liu Y; Xia W; Zou M; Wang J; Su H; Xu D
Mol Biol Rep; 2013 Jan; 40(1):59-65. PubMed ID: 23135732
[TBL] [Abstract][Full Text] [Related]
12. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
13. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.
Goncharov T; Hedayati S; Mulvihill MM; Izrael-Tomasevic A; Zobel K; Jeet S; Fedorova AV; Eidenschenk C; deVoss J; Yu K; Shaw AS; Kirkpatrick DS; Fairbrother WJ; Deshayes K; Vucic D
Mol Cell; 2018 Feb; 69(4):551-565.e7. PubMed ID: 29452636
[TBL] [Abstract][Full Text] [Related]
14. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
Zhang W; Wang Y
Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of receptor-interacting serine/threonine kinase 2 (RIP2) of the goldfish (Carassius auratus L.).
Xie J; Belosevic M
Dev Comp Immunol; 2015 Jan; 48(1):76-85. PubMed ID: 25242011
[TBL] [Abstract][Full Text] [Related]
16. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.
Chin AI; Dempsey PW; Bruhn K; Miller JF; Xu Y; Cheng G
Nature; 2002 Mar; 416(6877):190-4. PubMed ID: 11894097
[TBL] [Abstract][Full Text] [Related]
17. The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.
Condé C; Rambout X; Lebrun M; Lecat A; Di Valentin E; Dequiedt F; Piette J; Gloire G; Legrand S
PLoS One; 2012; 7(7):e41005. PubMed ID: 22815893
[TBL] [Abstract][Full Text] [Related]
18. Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling.
Heymann MC; Winkler S; Luksch H; Flecks S; Franke M; Ruß S; Ozen S; Yilmaz E; Klein C; Kallinich T; Lindemann D; Brenner S; Ganser G; Roesler J; Rösen-Wolff A; Hofmann SR
J Immunol; 2014 May; 192(9):4379-85. PubMed ID: 24706726
[TBL] [Abstract][Full Text] [Related]
19. RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NF‑κB and p38 signaling pathways.
Cai X; Yang Y; Xia W; Kong H; Wang M; Fu W; Long M; Hu Y; Xu D
Oncol Rep; 2018 Jun; 39(6):2915-2923. PubMed ID: 29693188
[TBL] [Abstract][Full Text] [Related]
20. Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib.
Zhao Y; Zhang K; Li G; Zhang X; Shi D
PLoS One; 2015; 10(5):e0127334. PubMed ID: 25973846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]